Abstract
To investigate the specific mutations in PROP1, POU1F1, LHX3, and HESX1 genes in patients with combined pituitary hormone deficiency (CPHD) in Turkey. Seventy-six patients with CPHD were included in this study. Based on clinical, hormonal, and neuro-radiological data, relevant transcription factor genes were evaluated by Sanger sequencing and multiplex ligation-dependent probe amplification. Total frequency of mutations was 30.9 % in patients with CPHD. Frequency was significantly higher in familial patients (p = 0.001). Three different types of mutations in PROP1 gene (complete gene deletion, c.301-302delAG, a novel mutation; IVS1+2T>G) were found in 12 unrelated patients (21.8 %). Mutations in PROP1 gene were markedly higher in familial than in sporadic cases (58.8 vs. 5.3 %, p < 0.001). Homozygous complete gene deletion was the most common mutation in PROP1 gene (8/12) and was identified in six familial patients. Four different homozygous mutations [p.Q4X, novel mutations; exons 1–2 deletion, p.V153F, p.I244S] were detected in POU1F1 gene. Central precocious puberty was firstly observed in a sporadic-male patient with homozygous POU1F1 (p.I244S) mutation. A homozygous mutation in HESX1 gene (p.R160H) was detected in one patient. This study is the first to investigate specific mutations in CPHD patients in Turkey. Complete deletion in PROP1 gene was the most common mutation encountered in patients with CPHD. We believe that the results of this study will contribute to the establishment of genetic screening strategies in Turkey, as well as to the studies on phenotype–genotype correlations and early diagnosis of CPHD patients.
Similar content being viewed by others
References
J.S. Parks, M.R. Brown, D.L. Hurley, C.J. Phelps, M.P. Wajnrajch, Heritable disorders of pituitary development. J. Clin. Endocrinol. Metab. 84, 4362–4370 (1999)
M.T. Dattani, Novel insights into the aetiology and pathogenesis of hypopituitarism. Horm. Res. 62(Suppl 3), 1–13 (2004)
C.J. Romero, S. Nesi-Franca, S. Radovick, The molecular basis of hypopituitarism. Trends Endocrinol. Metab. 20, 506–511 (2009)
D.C. de Moraes, M. Vaisman, F.L. Conceicao, T.M. Ortiga-Carvalho, Pituitary development: a complex, temporal regulated process dependent on specific transcriptional factors. J. Endocrinol. 215, 239–245 (2012)
R. Pfaffle, J. Klammt, Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Best Pract. Res. Clin. Endocrinol. Metab. 25, 43–60 (2011)
C. Fluck, J. Deladoey, K. Rutishauser, A. Eble, U. Marti, W. Wu, P.E. Mullis, Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-Cys at codon 120 (R120C). J. Clin. Endocrinol. Metab. 83, 3727–3734 (1998)
D. Kelberman, K. Rizzoti, R. Lovell-Badge, I.C. Robinson, M.T. Dattani, Genetic regulation of pituitary gland development in human and mouse. Endocr. Rev. 30, 790–829 (2009)
R. Reynaud, F. Albarel, A. Savenau, N. Kaffel, F. Castinetti, P. Lecomte, R. Brauner, G. Simonin, J. Gaurdart, E. Carmano, A. Enjalbert, A. Barlier, T. Brue, Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. Eur. J. Endocrinol. 164, 457–465 (2011)
W. Bonfig, H. Krude, H. Schmidt, A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature. Eur. J. Pediatr. 170, 1017–1021 (2011)
S. Kurtoğlu, N. Hatipoğlu, M.M. Mazıcıoğlu, M.A. Akın, D. Çoban, S. Gökoğlu, O. Baştuğ, Body weight, length and head circumference at birth a cohort of Turkish newborns. J. Clin. Res. Pediatr. Endocrinol. 4, 132–139 (2012)
O. Neyzi, A. Furman, R. Bundak, H. Günoz, F. Darendeliler, F. Baş, Growth references for Turkish children aged 6 to 18 years. Acta Paediatr. 95, 1635–1641 (2006)
G. Gökçay, A. Furman, O. Neyzi, Updated growth curves for Turkish children aged 15 days to 60 months. Child Care Health Dev. 34, 454–463 (2008)
R. Bundak, A. Furman, H. Günöz, F. Darendeliler, F. Baş, O. Neyzi, Body mass index for Turkish children aged 6 to 18 years. Acta Paediatr. 95, 194–198 (2006)
M.B. Ranke, Diagnostics of endocrine function in children and adolescents, 2nd edn. (Barth (Edition J&J), Heidelberg-Leipzig, 1996)
R. Reynaud, M. Gueydan, A. Saveanu, S. Vallette-Kasic, A. Enjalbert, T. Brue, A. Barlier, Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J. Clin. Endocrinol. Metab. 91, 3329–3336 (2006)
J.M. Schwarz, C. Rödelsperger, M. Schuelke, D. Seelow, MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575–576 (2010)
I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. Kondrashov, S.R. Sunyaev, A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010)
J. Deladoey, C. Fluck, A. Buyukgebiz, B.V. Kuhlmann, A. Eble, P.C. Hindmarsh, W. Wu, P.E. Mullis, ‘Hot spot’ in the PROP1 gene responsible for combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 84, 1645–1650 (1999)
T.C. Vieria, V.T. Boldarine, J. Abucham, Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency. Arq. Bras. Endocrinol. Metab. 51, 1097–1103 (2007)
J.P. Turton, A. Mehta, J. Raza, K.S. Woods, A. Tiulpakov, J. Cassar, K. Chong, P.Q. Thomas, M. Eunice, A.C. Ammini, P.M. Bouloux, J. Starzyk, P.C. Hindmarsh, M.T. Dattani, Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clin. Endocrinol. 63, 10–18 (2005)
L.C.G. de Graaff, J. Argente, D.C.M. Veenma, M.L. Drent, A.G. Litterlinden, A.C.S. Hokken-Koelega, PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency. Horm. Res. Paediatr. 73, 363–373 (2010)
J.D. Cogan, W. Wu, J.A. Phillips, I.J. Arnhold, A. Agapito, O.V. Fofanova, M.G. Osorio, I. Bircan, A. Moreno, B.B. Mendonca, The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 83, 3346–3349 (1998)
R. Navardauskai, P. Dusatkova, B. Obermannova, R.W. Pfaella, W.F. Blum, D. Adukauskiene, N. Smetanina, O. Cinek, R. Verkauskiene, J. Lebl, High prevalence of PROP1 defects in Lithuania: phenotypic findings in ethnically homogenous cohort of patients with multiple pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 99, 299–306 (2014)
K. McLennan, Y. Jeske, A. Cotterill, D. Cowley, J. Penfold, T. Jones, N. Howard, M. Thomsett, C. Choong, Combined pituitary hormone deficiency in Australian children: clinical and genetic corraletes. Clin. Endocrinol. 58, 785–794 (2003)
L.A. Rainbow, S.A. Rees, M.G. Shaikh, N.J. Shaw, T. Cole, T.G. Barrett, J.M.W. Kirk, Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clin. Endocrinol. 62, 163–168 (2005)
N. Kandemir, D. Vurallı, E. Taşkıran, N. Gönç, A. Ozon, A. Alikaşifoğlu, E. Yılmaz, Frequency of mutation in PROP1 gene in Turkish children with combined pituitary hormone deficiency. Turk. J. Pediatr. 54, 570–575 (2012)
A. Akçay, K. Ulucan, N. Taşkın, M. Boyraz, T. Akçay, O. Zurita, A. Gomez, K.E. Heath, A. Campos-Barros, Suprasellar mass mimicking a hypothalamic glioma in a patient with a complete PROP1 deletion. Eur. J. Med. Genet. 56, 445–451 (2013)
M.G. Abrao, M.V. Leite, L.R. Carvalho, A.E.C. Billerbeck, M.Y. Nishi, A.S. Barbosa, R.M. Martin, I.J.P. Arnhold, B.B. Mendonca, Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clin. Endocrinol. 65, 294–300 (2006)
S. Valette-Kasic, A. Barlier, C. Teinturier, A. Diaz, M. Manavela, F. Berthzene, P. Bouchard, J.L. Chaussain, R. Brauner, I. Pellegrini-Bouiller, P. Jaquet, A. Enjalbert, T. Brue, PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and high incidence of corticotroph deficiency. J. Clin. Endocrinol. Metab. 86, 4529–4535 (2001)
A. Mehta, P.C. Hindmarsh, H. Mehta, J.P.G. Turton, I. Russell-Eggitts, D. Taylor, W.K. Chong, M.T. Dattani, Congenital hypopituitarism: clinical, molecular and neuroradiological correlates. Clin. Endocrinol. 71, 376–382 (2009)
J. Lebl, J. Vosahlo, R.W. Pfaeffle, H. Stobbe, J. Cerna, D. Novotna, J. Zapletalova, B. Kalvachova, V. Hana, V. Weiss, W. Blum, Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects. Eur. J. Endocrinol. 153, 389–396 (2005)
J.P.G. Turton, R. Reynaud, A. Mehta, J. Torpiano, A. Savenau, K.S. Woods, A. Tiulpakov, V. Zdravkovic, J. Hamilton, S. Attard-Montalto, R. Parascandalo, C. Vella, P.E. Clayton, S. Shalet, J. Barton, T. Brue, M.T. Dattani, Novel mutations within POU1F1 gene associated with variable combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 90, 4762–4770 (2005)
J.S. Winter, W. De Groot, C. Faiman, Idiopathic sexual precocity in a boy with growth hormone, prolactin and thyrotropin deficiencies. J. Clin. Endocrinol. Metab. 39, 356–363 (1974)
A. Ladjouze, S. Soskin, C. Garel, M. Jullien, C. Naud-Saudreau, G. Pinto, P. Czernichow, J. Leger, GH deficiency with central precocious puberty: a new rare disorder associated with a developmental defect of the hypothalamic-pituitary area. Eur. J. Endocrinol. 156, 463–469 (2007)
J.S. Dasen, S.M. O’Connell, S.E. Flynn, M. Treier, A.S. Gleiberman, D.P. Szeto, F. Hooshmand, A.K. Aggarwal, M.G. Rosenfeld, Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 97, 587–598 (1999)
A. Lo, W. Zheng, Y. Gong, J.R. Crochet, L.M. Halvorson, GATA transcription factors regulate LHβ gene expression. J. Mol. Endocrinol. 47, 45–58 (2011)
B. Durmaz, O. Cogulu, C. Dizdarer, H. Stobbe, R. Pfaeffle, F. Ozkinay, A novel homozygous HESX1 mutation causes panhypopituitarism without midline defects and optic nerve anomalies. J. Pediatr. Endocrinol. Metab. 24, 779–782 (2011)
L.R. Carvalho, K.S. Woods, B.B. Mendonca, N. Marcal, A.L. Zamparini, S. Stifani, J.M. Brickman, I.J. Arnhold, M.T. Dattani, A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J. Clin. Invest. 112, 1192–1201 (2003)
Acknowledgments
This work was supported by Scientific and Technological Research Institution of Turkey (Project Number: 106S277-SBAG-3488) and Scientific Research Projects Coordination Unit of Istanbul University (Project Number: 2871). The authors would like to thank Professor Olcay Neyzi, MD, of the Istanbul Faculty of Medicine, Istanbul University, for helpful discussions and critical reading of the manuscript.
Conflict of interest
The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Baş F, Uyguner ZO and Darendeliler F have contributed equally to this work and could be considered as first authors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Baş, F., Uyguner, Z.O., Darendeliler, F. et al. Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study. Endocrine 49, 479–491 (2015). https://doi.org/10.1007/s12020-014-0498-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0498-1